Journal of Skin and Stem Cell

Published by: Kowsar

Anti-Malassezia IgE in Patients with Atopic Eczema Before and After Treatment with Ketoconazole Shampoo

Najmosadat Atefi 1 , Mohammad Nabavi 1 , Shooka Esmaeeli 1 , Zahra Azizian 1 , * , Hadi Mohagheghian 1 and Shima Javadinia 2
Authors Information
1 Iran University of Medical Sciences, Tehran, Iran
2 Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: September 30, 2018, 5 (3); e84047
  • Published Online: October 31, 2018
  • Article Type: Research Article
  • Received: September 8, 2018
  • Revised: October 19, 2018
  • Accepted: October 24, 2018
  • DOI: 10.5812/jssc.84047

To Cite: Atefi N , Nabavi M , Esmaeeli S , Azizian Z, Mohagheghian H , et al. Anti-Malassezia IgE in Patients with Atopic Eczema Before and After Treatment with Ketoconazole Shampoo, J Skin Stem Cell. 2018 ; 5(3):e84047. doi: 10.5812/jssc.84047.

Copyright © 2018, Journal of Skin and Stem Cell. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Horii KA, Simon SD, Liu DY, Sharma V. Atopic dermatitis in children in the United States, 1997 - 2004: Visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. 2007;120(3):e527-34. doi: 10.1542/peds.2007-0289. [PubMed: 17766497].
  • 2. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol. 2003;112(6 Suppl):S140-50. doi: 10.1016/j.jaci.2003.09.031. [PubMed: 14657844].
  • 3. Cipriani F, Dondi A, Ricci G. Recent advances in epidemiology and prevention of atopic eczema. Pediatr Allergy Immunol. 2014;25(7):630-8. doi: 10.1111/pai.12309. [PubMed: 25406640].
  • 4. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: Results from a cross-sectional study. Clin Exp Allergy. 2005;35(10):1301-8. doi: 10.1111/j.1365-2222.2005.02350.x. [PubMed: 16238789].
  • 5. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch Dis Child. 2005;90(9):892-7. doi: 10.1136/adc.2004.060673. [PubMed: 15863468]. [PubMed Central: PMC1720555].
  • 6. Van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA. Severe atopic dermatitis treated with everolimus. J Dermatolog Treat. 2009;20(6):365-7. doi: 10.3109/09546630903085294. [PubMed: 19954394].
  • 7. Leung DYM, Bieber T. Atopic dermatitis. The Lancet. 2003;361(9352):151-60. doi: 10.1016/s0140-6736(03)12193-9.
  • 8. Abramovits W. Atopic dermatitis. J Am Acad Dermatol. 2005;53(1 Suppl 1):S86-93. doi: 10.1016/j.jaad.2005.04.034. [PubMed: 15968268].
  • 9. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112(6 Suppl):S128-39. doi: 10.1016/j.jaci.2003.09.032. [PubMed: 14657843].
  • 10. Jansen CT, Haapalahti J, Hopsu-Havu VK. Immunoglobulin E in the human atopic skin. Archiv fur dermatologische Forschung. 1973;246(4):299-302.
  • 11. Bayrou O, Pecquet C, Flahault A, Artigou C, Abuaf N, Leynadier F. Head and neck atopic dermatitis and malassezia-furfur-specific IgE antibodies. Dermatology. 2005;211(2):107-13. doi: 10.1159/000086438. [PubMed: 16088155].
  • 12. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000;38(5):337-41. [PubMed: 11092380].
  • 13. Glatz M, Buchner M, von Bartenwerffer W, Schmid-Grendelmeier P, Worm M, Hedderich J, et al. Malassezia spp-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol. 2015;95(2):191-6. doi: 10.2340/00015555-1864. [PubMed: 24696225].
  • 14. Aspres N, Anderson C. Malassezia yeasts in the pathogenesis of atopic dermatitis. Australas J Dermatol. 2004;45(4):199-205. quiz 206-7. doi: 10.1111/j.1440-0960.2004.00097.x. [PubMed: 15527428].
  • 15. Back O, Bartosik J. Systemic ketoconazole for yeast allergic patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2001;15(1):34-8. [PubMed: 11451319].
  • 16. Lintu P, Savolainen J, Kortekangas-Savolainen O, Kalimo K. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy. 2001;56(6):512-7. [PubMed: 11421895].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments